XML 46 R7.htm IDEA: XBRL DOCUMENT v3.19.3
Condensed Consolidated Statements of Shareholders' Equity and Noncontrolling Interest - USD ($)
shares in Thousands, $ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Other Comprehensive (Loss) Income
Accumulated Deficit
Total Vertex Shareholders’ Equity
Noncontrolling Interest
Balance (shares) at Dec. 31, 2017   253,253          
Beginning Balance at Dec. 31, 2017 $ 2,042,306 $ 2,512 $ 7,157,362 $ (11,572) $ (5,119,723) $ 2,028,579 $ 13,727
Increase (Decrease) in Stockholders' Equity              
Other comprehensive income, net of tax 35,999     35,999   35,999  
Net income (loss) 562,007       546,369 546,369 15,638
Repurchases of common stock (in shares)   (1,283)          
Repurchases of common stock (211,038) $ (13) (211,025)     (211,038)  
Issuance of common stock under benefit plans (shares)   3,641          
Issuance of common stock under benefit plans 250,420 $ 52 250,368     250,420  
Stock-based compensation expense 246,558   246,558     246,558  
Other VIE activity (1,000)           (1,000)
Balance (shares) at Sep. 30, 2018   255,611          
Ending Balance at Sep. 30, 2018 2,934,481 $ 2,551 7,443,263 307 (4,540,005) 2,906,116 28,365
Balance (shares) at Jun. 30, 2018   254,883          
Beginning Balance at Jun. 30, 2018 2,714,883 $ 2,542 7,357,042 (4,605) (4,668,751) 2,686,228 28,655
Increase (Decrease) in Stockholders' Equity              
Other comprehensive income, net of tax 4,912     4,912   4,912  
Net income (loss) 128,456       128,746 128,746 (290)
Repurchases of common stock (in shares)   (515)          
Repurchases of common stock (92,004) $ (5) (91,999)     (92,004)  
Issuance of common stock under benefit plans (shares)   1,243          
Issuance of common stock under benefit plans 92,793 $ 14 92,779     92,793  
Stock-based compensation expense 85,441   85,441     85,441  
Balance (shares) at Sep. 30, 2018   255,611          
Ending Balance at Sep. 30, 2018 2,934,481 $ 2,551 7,443,263 307 (4,540,005) 2,906,116 28,365
Increase (Decrease) in Stockholders' Equity              
Cumulative effect adjustment for adoption of new accounting guidance       (24,120)      
Balance (shares) at Dec. 31, 2018   255,172          
Beginning Balance at Dec. 31, 2018 4,435,203 $ 2,546 7,421,476 659 (2,989,478) 4,435,203 0
Increase (Decrease) in Stockholders' Equity              
Other comprehensive income, net of tax 18,188     18,188   18,188  
Net income (loss) 593,576       593,576 593,576  
Repurchases of common stock (in shares)   (931)          
Repurchases of common stock (167,954) $ (9) (167,945)     (167,954)  
Issuance of common stock under benefit plans (shares)   3,024          
Issuance of common stock under benefit plans 144,557 $ 34 144,523     144,557  
Stock-based compensation expense 270,134   270,134     270,134  
Balance (shares) at Sep. 30, 2019   257,265          
Ending Balance at Sep. 30, 2019 5,253,394 $ 2,571 7,668,188 18,847 (2,436,212) 5,253,394 0
Balance (shares) at Jun. 30, 2019   256,671          
Beginning Balance at Jun. 30, 2019 5,069,965 $ 2,565 7,564,331 (3,201) (2,493,730) 5,069,965 0
Increase (Decrease) in Stockholders' Equity              
Other comprehensive income, net of tax 22,048     22,048   22,048  
Net income (loss) 57,518       57,518 57,518  
Repurchases of common stock (in shares)   (71)          
Repurchases of common stock (12,105)   (12,105)     (12,105)  
Issuance of common stock under benefit plans (shares)   665          
Issuance of common stock under benefit plans 30,012 $ 6 30,006     30,012  
Stock-based compensation expense 85,956   85,956     85,956  
Balance (shares) at Sep. 30, 2019   257,265          
Ending Balance at Sep. 30, 2019 $ 5,253,394 $ 2,571 $ 7,668,188 $ 18,847 $ (2,436,212) $ 5,253,394 $ 0